Inhibition of tissue factor limits the growth of venous thrombus in the rabbit

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 5, 2003, Pages 889-895

  Hiaaber, J ^a   Wohlgensinger, C ^a   Roux, S ^a,e   Damico, L A ^b   Fallon, J T ^c   Kirchhofer, D ^b   Nemerson, Y ^d   Riederer, M A ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b GENENTECH INC   (United States)

^c Cardiovascular Institute   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

Leukocytes; Thrombus; Tissue factor; Vein

Indexed keywords

EID: 84858628644     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00110.x     Document Type: Article

References (52)

1. Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8.
2. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-70.
3. Jang IK, Gold HK, Leinbach RC, Fallon JT, Collen D, Wilcox JN. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb 1992; 12: 948-54.
4. Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253-9.
5. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg WK, Ezekowitz MD. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994; 74: 56-63.
6. Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation 1995; 92: 3323-30.
7. Harker LA, Hanson SR, Wilcox JN, Kelly AB. Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis 1996; 26 (Suppl. 1): 76-82.
8. Himber J, Kirchhofer D, Riederer M, Tschopp TB, Steiner B, Roux S. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function. Thromb Haemost 1997; 78: 1142-9.
9. Kelley RF, Refino CJ, O'Connell MP, Modi N, Sehl P, Lowe D, Pater C, Bunting S. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent. Blood 1997; 89: 3219-27.
10. Murphy MK, La Chance RM, Stillwell LI, Torr-Brown SR, Girard TJ. Inhibiting factor VIIa-TF activity effectively prevents thrombosis with out bleeding side effects. Blood 1997; 90 (Suppl 1): 118-III.
11. Golino P, Ragni M, Cirillo P, D'Andrea D, Scognamiglio A, Ravera A, Buono C, Ezban M, Corcione N, Vigorito F, Condorelli M, Chiariello M. Antithrombotic effects of recombinant human active site-blocked factor VII in a rabbit model of recurrent arterial thrombosis. Circ Res 1998; 82: 39-46.
12. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
13. Moreno PR, Bernardi VH, Lopez Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94: 3090-7.
14. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-32.
15. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-9.
16. Fuster V, Fallon JT, Badimon JJ, Nemerson Y. The unstable athero sclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost 1997; 78: 247-55.
17. Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L. Local inhibition of tissue factor reduces the thrombogeni city of disrupted human atherosclerotic plaques. Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 1999; 99: 1780-7.
18. Corseaux D, Le Tourneau T, Six I, Ezekowitz MD, McFadden EP, Meurice T, Asseman P, Bauters C, Jude B. Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholes-terolemic rabbit: inhibition with dietary L-arginine. Circulation 1998; 98: 1776-82.
19. Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard PB, Petersen JG, Nielsen G, Hedner U. Antithrombotic effect of recombinant trun cated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis - a comparison with low molecular weight heparin. Thromb Haemost 1994; 71: 214-9.
20. Holst J, Kristensen AT, Kristensen HI, Ezban M, Hedner U. Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model. Eur J Vasc Endovasc Surg 1998; 15: 515-20.
21. Lerner RG, Goldstein R, Nelson JC. Production of thromboplastin (tissue factor) and thrombi by polymorphonuclear neutrophilic leuko cytes adhering to vein walls. Thromb Res 1977; 11: 11-22.
22. Ragni M, Cirillo P, Pascucci I, Scognamiglio A, D'Andrea D, Eramo N, Ezekowitz MD, Pawashe AB, Chiariello M, Golino P. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation 1996; 93: 1913-8.
23. Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemost 1987; 58: 1078-84.
24. Agnelli G, Buchanan MR, Fernandez F, Boneu B, Van Ryn J, Hirsh J, Collen D. A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. Circulation 1985; 72: 178-82.
25. Hilpert K, Ackermann J, Banner DW, Gast A, Gubernator K, Hadvary P, Labler L, Muller K, Schmid G, Tschopp TB, Van de Waterbeemd H. Design and synthesis of potent and highly selective thrombin inhibitors. J Med Chem 1994; 37: 3889-901.
26. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996; 75: 451-61.
27. Grabowski EF. Effects of contrast media on endothelial cell mono-layers under controlled flow conditions. Am J Cardiol 1989; 64: 10E-15E.
28. Dvorak HF, Van De Water L, Bitzer AM, Dworak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho AC. Procoagulant activity associated with plasma membranes vesicles shed by cultured tumor cells. Cancer Res 1983; 43: 4434-42.
29. Lewis JC, Bennett-Cain AL, DeMars CS, Doellgast GJ, Grant KW, Jones NL, Gupta M. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol 1995; 147: 1029-40.
30. Wakefield TW, Greenfield LJ, Rolfe MW, DeLucia A, Strieter RM, Abrams GD, Kunkel SL, Esmon CT, Wrobleski SK, Kadell AM. Inflammatory and procoagulant mediator interactions in an experimen tal baboon model of venous thrombosis. Thromb Haemost 1993; 69: 164-72.
31. Johnson K, Aarden L, Choi Y, De Groot E, Creasey A. The proin-flammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87: 5051-60.
32. Ikeda K, Nagasawa K, Horiuchi T, Tsuru T, Nishizaka H, Niho Y C5a induces tissue factor activity on endothelial cells. Thromb Haemost 1997; 77: 394-8.
33. Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ. Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 1997; 5: 6-15.
34. Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998; 160: 5130-5.
35. Giesen PLA, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
36. Osterud B. Tissue factor expression in monocytes: In vitro compared to ex vivo. Thromb Haemost 2000; 84: 521-2.
37. Erlich J, Fearns C, Mathison J, Ulevitch RJ, Mackman N. Lipopoly-saccharide induction of tissue factor expression in rabbits. Infect Immun 1999; 67: 2540-6.
38. Drake TA, Cheng J, Chang A, Taylor FB Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1-13.
39. Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ. Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993; 143: 76-84.
40. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
41. Osterud B, Rao LVM, Olsen JO. Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expres sion in granulocytes. Thromb Haemost 2000; 83: 861-7.
42. Lerner RG, Goldstein R, Cummings G. Endotoxin induced disseminated intravascular clotting: evidence that it is mediated by neutrophil pro duction of tissue factor. Thromb Res 1977; 11: 253-61.
43. Todoroki H, Nakamura S, Higure A, Okamoto K, Takeda S, Nagata N, Itoh H, Ohsato K. Neutrophils express tissue factor in a monkey model of sepsis. Surgery 2000; 127: 209-16.
44. Higure A, Okamoto K, Hirata K, Todoroki H, Nagafuchi Y, Takeda S, Katoh H, Itoh H, Ohsato K, Nakamura S. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis. Thromb Haemost 1996; 75: 791-5.
45. Todoroki H, Higure A, Okamoto K, Okazaki K, Nagafuchi Y, Takeda S, Katoh H, Itoh H, Ohsato K, Nakamura S. Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils. J Surg Res 1998; 80: 149-55.
46. Himber J, Kling D, Fallon JT, Nemerson Y, Riederer MA. In situ localization of tissue factor in human thrombi. Blood 2002; 99: 4249-50.
47. McKenzie CR, Abendschein DR, Eisenberg PR. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factorXa.ArteriosclerThromb VascBiol 1996; 16: 1285-91.
48. Key NS, Slungaard A, Dandelet L, Nelson SC, Moertel C, Styles LA, Kuypers FA, Bach RR. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91: 4216-23.
49. Fukuda C, Iijima K, Nakamura K. Measuring tissue factor (factor III) activity in plasma, din Chem 1989; 35: 1897-900.
50. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kamikubo Y, Nakamura S. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997; 134: 253-9.
51. Niemetz J, Marcus AJ. The stimulatory effects of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest 1974; 54: 1437-43.
52. Stewart GJ. Neutrophils and deep venous thrombosis. Haemostasis 1993; 23 (Suppl. 1): 127-4